title: Can expedited FDA drug approval without expedited follow-up be trusted?
authors.affiliation: Department of Government and Center for American Political Studies, Radcliffe Institute for Advanced Study, Harvard University, Cambridge, Massachusetts.
authors.forename: Daniel
authors.initials: D
authors.lastname: Carpenter
mesh_terms: D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D017277:Drug Approval / Q000706:statistics & numerical data*; D055808:Drug Discovery / Q000706:statistics & numerical data*; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data*